STENTYS

stentys-logo

STENTYS S.A. developing and commercializing solutions for treating patients with acute myocardial infarction in Europe, the Middle East, Asia, and Latin America.

#SimilarOrganizations #People #Financial #Website #More

STENTYS

Social Links:

Industry:
Health Care Health Diagnostics Medical Device

Founded:
2006-01-01

Address:
Paris, Ile-de-France, France

Country:
France

Website Url:
http://www.stentys.com

Total Employee:
11+

Status:
Active

Contact:
33 1 44 53 99 42

Email Addresses:
info@stentys.com

Total Funding:
53.6 M USD

Technology used in webpage:
Domain Not Resolving SPF Google Font API Content Delivery Network Font Awesome JsDelivr Cloudflare JS CDN JS Google Apps For Business BootstrapCDN


Similar Organizations

injectsense-logo

Injectsense

Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.

joint-academy-logo

Joint Academy

Joint Academy connects patients with licensed physical therapists to deliver online treatments for chronic joint and back pain.

resapp-health-logo

ResApp Health

ResApp is developing digital healthcare solutions to assist doctors

seno-medical-instruments-logo

Seno Medical Instruments

Seno Medical is commercialization efforts in opto-acoustic imaging of breast cancer.


Current Advisors List

alexia-perouse_image

Alexia Perouse Board of Directors @ Stentys
Board_member

antoine-papiernik_image

Antoine Papiernik Board of Directors @ Stentys
Board_member

michel-darnaud_image

Michel Darnaud Chairman @ Stentys
Board_member

michael-lesh_image

Michael Lesh Board of Directors @ Stentys
Board_member

Current Employees Featured

lottin-christophe_image

Lottin Christophe
Lottin Christophe CEO @ Stentys
CEO
2016-07-01

Founder


gonzague-issenmann_image

Gonzague Issenmann

Stock Details


Company's stock symbol is EPA:STNT

Acquisitions List

Date Company Article Price
2018-01-30 MINVASYS SAS MINVASYS SAS acquired by Stentys N/A
2014-06-12 Cappella Peel Away Cappella Peel Away acquired by Stentys N/A

Investors List

omnes-capital_image

Omnes Capital

Omnes Capital investment in Series B - Stentys

scottish-equity-partners_image

Scottish Equity Partners

Scottish Equity Partners investment in Series B - Stentys

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Series B - Stentys

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Series A - Stentys

scottish-equity-partners_image

Scottish Equity Partners

Scottish Equity Partners investment in Series A - Stentys

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Seed Round - Stentys

Official Site Inspections

http://www.stentys.com

  • Host name: 23.102.12.43
  • IP address: 23.102.12.43
  • Location: Dublin Ireland
  • Latitude: 53.3338
  • Longitude: -6.2488
  • Timezone: Europe/Dublin
  • Postal: D02

Loading ...

More informations about "Stentys"

Stentys - Crunchbase Company Profile & Funding

STENTYS S.A. developing and commercializing solutions for treating patients with acute myocardial infarction in Europe, the Middle East, Asia, and Latin America.See details»

Stentys Company Profile 2024: Valuation, Funding & Investors

Stentys General Information Description. Stentys is engaged in designing, developing, and marketing self-expanding stents used in treating cardiovascular diseases in the treatment of …See details»

Stentys - Company Profile and News - Bloomberg Markets

Company profile page for Stentys including stock price, company news, executives, board members, and contact informationSee details»

Stentys: Shareholders Board Members Managers and Company …

Stentys: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Börse Stuttgart: SYN | Börse StuttgartSee details»

Stentys - Ownership and Business Overview - Mergr

Stentys develops and commercializes innovative solutions for the treatment of patients with complex artery disease. STENTYS’ Self-Apposing drug-eluting stents (DES) are designed to …See details»

Company Stentys CINNOBER BOAT - MarketScreener.com

Stentys: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | CINNOBER BOAT: 0OMV | CINNOBER BOATSee details»

Stentys - Overview, News & Similar companies | ZoomInfo.com

Who is Stentys. STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS' Self-Apposing dr ug-eluting …See details»

Stentys - Funding, Financials, Valuation & Investors - Crunchbase

Stentys is a Coronary artery bifurcation stenosis treatment developer. How much funding has this organization raised over time? ShowSee details»

STENTYS - VentureRadar

"Stentys has developed a patented product to treat specific cardiac artery diseases and avoid open-chest surgery for hundreds of thousands of patients.See details»

Stentys Inc. Company Profile | Princeton, NJ - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Stentys Inc. of Princeton, NJ. Get the latest business insights from Dun & Bradstreet.See details»

Stentys: Governance, Directors and Executives & Committees

Find the composition of the Board of Directors of Stentys (Börse Stuttgart Stock Exchange), the gender parity as well as the age distribution of the insiders.See details»

Stentys - Products, Competitors, Financials, Employees, …

Drug-Eluting Stents Market: Key Players, Trends, and Strategic Insights by 2032 | CAGR 8.7%. Jul 15, 2024 | CAGR 8.7% News Provided By Share This Article Drug-Eluting Stents Market …See details»

Stentys - HealthManagement.org

STENTYS ® offers innovative solutions to the interventional cardiologist in the treatment of patients with acute myocardial infarction and other complex coronary disease. The STENTYS …See details»

Governance Stentys LIQUIDNET SYSTEMS - MarketScreener.com

Find the composition of the Board of Directors of Stentys (LIQUIDNET SYSTEMS Stock Exchange), the gender parity as well as the age distribution of the insiders.See details»

The STENTYS self-apposing stent technology in coronary artery …

Despite numerous theoretical advantages of the nitinol platform, superiority of the STENTYS self-apposing stent over currently available drug-eluting stents has not yet been proven. However, …See details»

(PDF) The STENTYS self-apposing® stent - ResearchGate

May 19, 2015 PDF | Name and manufacturer: The STENTYS Self-Apposing® stent; Stentys S.A., Paris, France. Approval status: CE mark in 2010 (for acute coronary... | Find, read and …See details»

Scentys - Crunchbase Company Profile & Funding

Scentys designs and develops automatic atmospheric perfume diffusers for shops (Tag Heuer, Vacheron Constantin, Bonpoint) and the hotel business (Hôtel Lancaster, Silencio Paris). …See details»

Scentys, Diffuseur de parfum pro | Spécialiste en Marketing Olfactif

Scentys : Expert en marketing olfactif et diffusion de parfums pour professionnels. Création de diffuseurs, signature olfactive pour lancement produit, évènement ou parfumage d'espace.See details»

Scentsy | Company Overview & News - Forbes

Scentsy, Inc.(www.scentsy.com) offers innovative and customizable products that Warm the Heart, Enliven the Senses and Inspire the Soul. Scentsy featuresSee details»

Scentys is innovating in home fragrance with an eye to …

Sep 11, 2023 Scentys has been innovating and pushing the boundaries of the fragrance diffusion market since 2004. Starting with the fragrance capsule technology it invented and …See details»

linkstock.net © 2022. All rights reserved